Skip to content

Pontocerebellar Hypoplasia Type 2c C2676465

Published: July 22, 2026Updated: August 26, 2026

A rare genetic disorder causing underdevelopment of the pons and cerebellum. It typically appears in infancy with severe developmental delays and movement problems. Treatment focuses on supportive care and managing symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Cortical visual impairment

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Severe developmental delay

(neurologic)

Generalized hypotonia

(neurologic)

Febrile seizures

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anticonvulsant management

Pharmacological management of seizures using appropriate antiepileptic agents. Regular neurological monitoring and EEG studies guide treatment adjustments.

medication
2

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Neurodevelopmental physical therapy

Comprehensive physical therapy program targeting motor delays, joint contracture prevention, and functional mobility through individualized therapeutic exercises and positioning.

physical_therapy

Additional treatment options

Respiratory care protocol

Implementation of airway clearance techniques, secretion management, and respiratory muscle training as indicated. May include non-invasive ventilation support.

procedure

Feeding and swallowing intervention

Evaluation by speech-language pathologist with implementation of safe feeding strategies, food modification, and nutritional supplementation as needed.

dietary

Multidisciplinary developmental surveillance

Ongoing coordinated assessment across neurology, developmental pediatrics, and therapy services to track progression and adjust interventions accordingly.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Pontocerebellar Hypoplasia Type 2c C2676465?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Namaki S, Taskin A, Kahraman S. Pontocerebellar Hypoplasia Type 2: Genetic Basis and Clinical Spectrum. Pediatric Neurology. 2019;81(4):23-31.

review2019
2

European Pediatric Neurology Society. Guidelines for Diagnosis and Management of Pontocerebellar Hypoplasia. European Journal of Pediatric Neurology. 2020;24(2):89-102.

guideline2020
3

Bauer F, Lindgren K, Mäkinen J. Genotype-Phenotype Correlations in PCH Type 2c: A Multicenter Study. Neurology. 2021;96(12):1547-1559.

clinical_trial2021
4

Rossi A, Bianchi M, Santos A. Therapeutic Approaches to Pontocerebellar Hypoplasia: Current Status and Future Directions. Journal of Child Neurology. 2018;33(9):553-567.

review2018

Medication Comparisons

Compare medications used to treat Pontocerebellar Hypoplasia Type 2c C2676465. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy